z-logo
open-access-imgOpen Access
Doxycycline enhances adsorption and inhibits early-stage replication of porcine reproductive and respiratory syndrome virus in vitro
Author(s) -
Yuming Li,
Zhuanchang Wu,
Ke Liu,
Pengfei Qi,
Jinpeng Xu,
Jianchao Wei,
Beibei Li,
Donghua Shao,
Yuanyuan Shi,
Yafeng Qiu,
Zhiyong Ma
Publication year - 2017
Publication title -
fems microbiology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 151
eISSN - 1574-6968
pISSN - 0378-1097
DOI - 10.1093/femsle/fnx170
Subject(s) - porcine reproductive and respiratory syndrome virus , doxycycline , cytopathic effect , virology , viral replication , biology , in vitro , virus , tetracycline , microbiology and biotechnology , respiratory system , antibiotics , biochemistry , anatomy
Porcine reproductive and respiratory syndrome virus (PRRSV) has an important impact on the pig industry. Doxycycline (Dox) is a second-generation tetracycline widely used for treating bacterial infections. We evaluated the antiviral effect of Dox against PRRSV infection in Marc-145 cells that were susceptible to PRRSV infection. Dox significantly reduced the PRRSV-induced cytopathic effect and effectively restrained PRRSV replication in a dose-dependent manner. The 50% effective concentration of Dox was approximately 0.25 ± 0.05 μg/ml. We also determined the stage at which Dox influenced PRRSV replication, and showed that Dox enhanced PRRSV adsorption and inhibited the early stage of PRRSV replication after viral entry into host cells. These observations demonstrate that Dox is able to restrain PRRSV infection in cultured cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom